Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robert Leonard

Showing results (21-30 of 39) with videos related to

Pageof 4
Sort By:
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|March 23, 2010
Risk factors for chemotherapy-induced neutropenia occurrence in breast cancer patients: data from the INC-EU Prospective Observational European Neutropenia StudyMatthias Schwenkglenks, Ruth Pettengell, Christian Jackisch, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|March 21, 2008
Neutropenia occurrence and predictors of reduced chemotherapy delivery: results from the INC-EU prospective observational European neutropenia studyRuth Pettengell, Matthias Schwenkglenks, Robert Leonard, et al.
Retina (Philadelphia, Pa.)|May 25, 2011
Efficacy of vitrectomy in improving the outcome of Bacillus cereus endophthalmitisMichelle C Callegan, Scott Guess, Nanette R Wheatley, et al.
Medicines (Basel, Switzerland)|May 24, 2020
Heart Failure Drug Class Effects on 30-Day Readmission Rates in Patients with Heart Failure with Preserved Ejection Fraction: A Retrospective Single Center StudyPriyanka Parajuli, Odalys Estefania Lara-Garcia, Manjari Rani Regmi, et al.
Journal of Bone Oncology|March 22, 2016
Goserelin, as an ovarian protector during (neo)adjuvant breast cancer chemotherapy, prevents long term altered bone turnoverCaroline Wilson, Fatma Gossiel, Robert Leonard, et al.
Retina (Philadelphia, Pa.)|August 10, 2013
Clinical course of vitreomacular adhesion managed by initial observationVishak J John, Harry W Flynn, William E Smiddy, et al.
The Lancet. Oncology|December 11, 2002
Chemotherapy for metastatic breast cancer-report of a European expert panelJohn Crown, Véronique Diéras, Manfred Kaufmann, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|April 20, 2006
Neutropenic event risk and impaired chemotherapy delivery in six European audits of breast cancer treatmentMatthias Schwenkglenks, Christian Jackisch, Manuel Constenla, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|August 27, 2017
Refining the role of pegfilgrastim (a long-acting G-CSF) for prevention of chemotherapy-induced febrile neutropenia: consensus guidance recommendationsMatti Aapro, Ralph Boccia, Robert Leonard, et al.
Pharmaceutics|October 29, 2025
Extracellular Vesicles and Nanoparticles in Regenerative and Personalised Medicine: Diagnostic and Therapeutic Roles-A Narrative ReviewElena Silvia Bernad, Ingrid-Andrada Vasilache, Robert Leonard Bernad, et al.
Pageof 4

Showing results (21-30 of 39) with videos related to

Sort By:
Pageof 4
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|March 23, 2010
Risk factors for chemotherapy-induced neutropenia occurrence in breast cancer patients: data from the INC-EU Prospective Observational European Neutropenia StudyMatthias Schwenkglenks, Ruth Pettengell, Christian Jackisch, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|March 21, 2008
Neutropenia occurrence and predictors of reduced chemotherapy delivery: results from the INC-EU prospective observational European neutropenia studyRuth Pettengell, Matthias Schwenkglenks, Robert Leonard, et al.
Retina (Philadelphia, Pa.)|May 25, 2011
Efficacy of vitrectomy in improving the outcome of Bacillus cereus endophthalmitisMichelle C Callegan, Scott Guess, Nanette R Wheatley, et al.
Medicines (Basel, Switzerland)|May 24, 2020
Heart Failure Drug Class Effects on 30-Day Readmission Rates in Patients with Heart Failure with Preserved Ejection Fraction: A Retrospective Single Center StudyPriyanka Parajuli, Odalys Estefania Lara-Garcia, Manjari Rani Regmi, et al.
Journal of Bone Oncology|March 22, 2016
Goserelin, as an ovarian protector during (neo)adjuvant breast cancer chemotherapy, prevents long term altered bone turnoverCaroline Wilson, Fatma Gossiel, Robert Leonard, et al.
Retina (Philadelphia, Pa.)|August 10, 2013
Clinical course of vitreomacular adhesion managed by initial observationVishak J John, Harry W Flynn, William E Smiddy, et al.
The Lancet. Oncology|December 11, 2002
Chemotherapy for metastatic breast cancer-report of a European expert panelJohn Crown, Véronique Diéras, Manfred Kaufmann, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|April 20, 2006
Neutropenic event risk and impaired chemotherapy delivery in six European audits of breast cancer treatmentMatthias Schwenkglenks, Christian Jackisch, Manuel Constenla, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|August 27, 2017
Refining the role of pegfilgrastim (a long-acting G-CSF) for prevention of chemotherapy-induced febrile neutropenia: consensus guidance recommendationsMatti Aapro, Ralph Boccia, Robert Leonard, et al.
Pharmaceutics|October 29, 2025
Extracellular Vesicles and Nanoparticles in Regenerative and Personalised Medicine: Diagnostic and Therapeutic Roles-A Narrative ReviewElena Silvia Bernad, Ingrid-Andrada Vasilache, Robert Leonard Bernad, et al.
Pageof 4